Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

DEPO-PROVERA vs RESNIBEN

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. DEPO-PROVERA and RESNIBEN are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

depo-proveraresniben

Rating

60/100
72/100

Pharmacy pays

~$553.74 /30
—

Type

RX
RX

Active ingredient

MEDROXYPROGESTERONE ACETATE
CABOZANTINIB

Manufacturer

Pfizer
Azurity

Dosage forms

Injectable
Tablet

Drug class

Progestin
—

Boxed warning

Boxed warning
None

Treats

Amenorrhea, Breast Neoplasms, Renal Cell Carcinoma
Renal Cell Carcinoma

Frequently asked questions

Which is better-rated, Depo-Provera or Resniben?

By our independent rating, Resniben scores higher — 3.6 vs 3.0 out of 5 for Depo-Provera. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Depo-Provera and Resniben?

Depo-Provera contains Medroxyprogesterone Acetate, while Resniben contains Cabozantinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.